Hikma Pharmaceuticals buy BNP Paribas
Start price
14.05.25
/
50%
€23.40
Target price
14.05.26
-
Performance (%)
-30.45%
Price
17.04.26
€15.51
Summary
This prediction is currently active. Massive losses of -30.45% have been the result for the BUY prediction by BNP_Paribas. A total of €0.41 was paid as dividends for this prediction. This prediction currently runs until 14.05.26. The prediction end date can be changed by BNP_Paribas at any time. BNP_Paribas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hikma Pharmaceuticals | 3.262% | 3.262% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by BNP_Paribas for this prediction
In the thread Hikma Pharmaceuticals diskutieren
Hikma Pharmaceuticals PLC (OTCMKTS: HKMPF) is now covered by analysts at BNP Paribas. They set an "outperform" rating on the stock.
Ratings data for HKMPF provided by MarketBeat